Current Management of Infantile Hemangiomas and Their Common Associated Conditions

Otolaryngologic Clinics of North America

Volumn 45, Issue 3, 2012, Pages 545-556

  Hartzell, Larry D ^a   Buckmiller, Lisa M ^a  

^a ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

Hemangioma; Hemangioma treatment; Infantile hemangioma; PHACES; Propranolol

Indexed keywords

ALPHA2A INTERFERON; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; PROPRANOLOL; TRIAMCINOLONE; VINCRISTINE;

ADRENAL SUPPRESSION; BEHAVIOR CHANGE; BRONCHOSPASM; CAPILLARY HEMANGIOMA; CEREBRAL PALSY; DEFORMITY; DISEASE ASSOCIATION; DISEASE COURSE; GASTROESOPHAGEAL REFLUX; GROWTH DISORDER; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INVOLUTION; LASER COAGULATION; NIGHTMARE; PAIN; RESPIRATORY DISTRESS; REVIEW; SIDE EFFECT; SOMNOLENCE; SYNDROME; TREATMENT INDICATION; TREATMENT OUTCOME; ULCER; UNSPECIFIED SIDE EFFECT;

ADRENERGIC BETA-ANTAGONISTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIVIRAL AGENTS; BRONCHOSCOPY; CONGENITAL ABNORMALITIES; DECISION MAKING; GLUCOCORTICOIDS; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HUMANS; INFANT; INTERFERON-ALPHA; LARYNGOSCOPY; LASERS, DYE; LUMBOSACRAL REGION; OFF-LABEL USE; PROPRANOLOL; RECOMBINANT PROTEINS; VINCRISTINE; WATCHFUL WAITING;

EID: 84860912676     PISSN: 00306665     EISSN: 15578259     Source Type: Journal    
DOI: 10.1016/j.otc.2012.03.001     Document Type: Review

References (41)

1. Jacobs A.H., Walton R.G. The incidence of birthmarks in the neonate. Pediatrics 1976, 58:218-222.
2. Chiller K.G., Passaro D., Frieden I.J. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 2002, 138:1567-1576.
3. Haggstrom A.N., Drolet B.A., Baselga E., et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007, 150:291-294.
4. Smolinski K.N., Yan A.C. Hemangiomas of infancy: clinical and biological characteristics. Clin Pediatr (Phila) 2005, 44:747-766.
5. Macarthur C.J. Head and neck hemangiomas of infancy. Curr Opin Otolaryngol Head Neck Surg 2006, 14:397-405.
6. Berg J.N., Walter J.W., Thisanagayam U., et al. Evidence for loss of heterozygosity of 5q in sporadic haemangiomas: are somatic mutations involved in haemangioma formation?. J Clin Pathol 2001, 54:249-252.
7. Walter J.W., Blei F., Anderson J.L., et al. Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet 1999, 82:77-83.
8. Blei F., Walter J., Orlow S.J., et al. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 1998, 134:718-722.
9. North P.E., Waner M., Mizeracki A., et al. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000, 31:11-22.
10. North P.E., Waner M., Mizeracki A., et al. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001, 137:559-570.
11. North P.E., Waner M., Brodsky M.C. Are infantile hemangiomas of placental origin?. Ophthalmology 2002, 109:633-634.
12. Burton B.K., Schulz C.J., Angle B., et al. An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn 1995, 15:209-214.
13. Mulliken J.B., Glowacki J. Classification of pediatric vascular lesions. Plast Reconstr Surg 1982, 70:120-121.
14. Haggstrom A.N., Lammer E.J., Schneider R.A., et al. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006, 117:698-703.
15. Waner M., North P.E., Scherer K.A., et al. The nonrandom distribution of facial hemangiomas. Arch Dermatol 2003, 139:869-875.
16. Mulliken J.B., Enjolras O. Congenital hemangiomas and infantile hemangioma: missing links. J Am Acad Dermatol 2004, 50:875-882.
17. Berenguer B., Mulliken J.B., Enjolras O., et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 2003, 6:495-510.
18. Krol A., MacArthur C.J. Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas. Arch Facial Plast Surg 2005, 7:307-311.
19. Enjolras O., Mulliken J.B., Boon L.M., et al. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001, 107:1647-1654.
20. Chang L.C., Haggstrom A.N., Drolet B.A., et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008, 122:360-367.
21. Orlow S.J., Isakoff M.S., Blei F. Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a "beard" distribution. J Pediatr 1997, 131:643-646.
22. Roganovic J., Adams D. PHACES syndrome-case report and literature review. Coll Antropol 2009, 33:311-314.
23. Cho Y.H., Taplin C., Mansour A., et al. Case report: consumptive hypothyroidism consequent to multiple infantile hepatic haemangiomas. Curr Opin Pediatr 2008, 20:213-215.
24. Peters C., Langham S., Mullis P.E., et al. Use of combined liothyronine and thyroxine therapy for consumptive hypothyroidism associated with hepatic haemangiomas in infancy. Horm Res Paediatr 2010, 74:149-152.
25. Leaute-Labreze C., Dumas de la Roque E., Hubiche T., et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008, 358:2649-2651.
26. Sans V., de la Roque E.D., Berge J., et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009, 124:e423-e431.
27. Fuchsmann C., Quintal M.C., Giguere C., et al. Propranolol as first-line treatment of head and neck hemangiomas. Arch Otolaryngol Head Neck Surg 2011, 137:471-478.
28. Buckmiller L.M., Munson P.D., Dyamenahalli U., et al. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center. Laryngoscope 2010, 120:676-681.
29. Zarem H.A., Edgerton M.T. Induced resolution of cavernous hemangiomas following prednisolone therapy. Plast Reconstr Surg 1967, 39:76-83.
30. Sadan N., Wolach B. Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr 1996, 128:141-146.
31. Boon L.M., MacDonald D.M., Mulliken J.B. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 1999, 104:1616-1623.
32. Shorr N., Seiff S.R. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma. Ophthalmic Surg 1986, 17:229-231.
33. Ruttum M.S., Abrams G.W., Harris G.J., et al. Bilateral retinal embolization associated with intralesional corticosteroid injection for capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus 1993, 30:4-7.
34. Boehm D.K., Kobrinsky N.L. Treatment of cavernous hemangioma with vincristine. Ann Pharmacother 1993, 27:981.
35. Perez Payarols J., Pardo Masferrer J., Gomez Bellvert C. Treatment of life-threatening infantile hemangiomas with vincristine. N Engl J Med 1995, 333:69.
36. Ezekowitz R.A., Mulliken J.B., Folkman J. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992, 326:1456-1463.
37. Ricketts R.R., Hatley R.M., Corden B.J., et al. Interferon-alpha-2a for the treatment of complex hemangiomas of infancy and childhood. Ann Surg 1994, 219:605-612. [discussion: 12-4].
38. Chang E., Boyd A., Nelson C.C., et al. Successful treatment of infantile hemangiomas with interferon-alpha-2b. J Pediatr Hematol Oncol 1997, 19:237-244.
39. Shafirstein G., Buckmiller L.M., Waner M., et al. Mathematical modeling of selective photothermolysis to aid the treatment of vascular malformations and hemangioma with pulsed dye laser. Lasers Med Sci 2007, 22:111-118.
40. Thomas R.F., Hornung R.L., Manning S.C., et al. Hemangiomas of infancy: treatment of ulceration in the head and neck. Arch Facial Plast Surg 2005, 7:312-315.
41. Hohenleutner S., Badur-Ganter E., Landthaler M., et al. Long-term results in the treatment of childhood hemangioma with the flashlamp-pumped pulsed dye laser: an evaluation of 617 cases. Lasers Surg Med 2001, 28:273-277.